Antiretroviral Therapy as HIV Prevention

There has been widespread debate about the role of ARV therapy in preventing HIV transmission since the publication of the ‘Swiss statement’ in January 2008. This discussion has intensified in the last two years with the publication of various epidemiological models that examine the potential impact of early and extensive ARV therapy—in relation to other proven interventions—on HIV transmission at a population level.

Although the debate is far from over, the AFAO-NAPWA Education Team invited a group of authors from the Australian HIV sector to consider the issue of ARV therapy as prevention with a particular focus on recent debates and their application to the Australian context, as well as wider implications. Each of these authors makes an important contribution to this question. The resulting Monograph, 'TRICK OR TREAT? Antiretroviral therapy as HIV prevention', is the first in AFAO's HIV Biomedical Prevention Series.

Download the Monograph (PDF, 312 KB, 71pp)

10 July 2010